Metformin and risk of vitamin B12 deficiency: new advice
Impact of Coverage of GLP-1 Drugs for Obesity on Medicare Expenditure s Source: JAMA Health Forum Hwang, April 25, 2025 Researchers in JAMA Health Forum used a microsimulation model to assess the likely financial results of Medicare covering GLP-1 drugs for obesity
The 15 metabolites contributing most to the separation of groups are reflected by high variable importance in projection (VIP) scores (bottom graph)
Blood 82 , 36103615 (1993)
While not as potent as GLP-1 or dual agonist therapies, Contrave remains a valuable option for select patients who need help managing behavioral and emotional components of eating
Mitch Biermann, an obesity medicine physician at Scripps Health in San Diego, said the practice is emblematic of a wider shift in his field, toward a more holistic assessment of excess fat and body composition